Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (5,461) Arrow Down
Filter Results: (5,461) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (5,461)
    • People  (26)
    • News  (1,545)
    • Research  (2,815)
    • Events  (16)
    • Multimedia  (34)
  • Faculty Publications  (1,643)

Show Results For

  • All HBS Web  (5,461)
    • People  (26)
    • News  (1,545)
    • Research  (2,815)
    • Events  (16)
    • Multimedia  (34)
  • Faculty Publications  (1,643)
← Page 81 of 5,461 Results →
  • 05 Feb 2008
  • First Look

First Look: February 5, 2008

Ostrovsky, and Schwarz. We prove that convergence occurs with probability 1, and we compute the expected time until convergence. Download the paper: http://www.hbs.edu/research/pdf/08-056.pdf Attracting Flows by Attracting Big Clients: Conflicts of Interest and Mutual... View Details
Keywords: Martha Lagace
  • January 2009 (Revised July 2009)
  • Case

Targanta Therapeutics: Hitting a Moving Target

By: Arthur A. Daemmrich
This case explores regulatory, product testing, and business strategy at Targanta Therapeutics, a biotech company preparing its first new drug application to the FDA. In October 2007, Mark Leuchtenberger, president and CEO of Targanta—which has just held a successful... View Details
Keywords: Decision Choices and Conditions; Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Product Development; Business and Government Relations; Business Strategy; Biotechnology Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Daemmrich, Arthur A. "Targanta Therapeutics: Hitting a Moving Target." Harvard Business School Case 709-002, January 2009. (Revised July 2009.)
  • Article

Investors as Stewards of the Commons?

By: George Serafeim
Over the past few years, there has been a significant increase in the number of initiatives seeking to mobilize investor voice towards positive social impact. In this paper, I provide a framework outlining the role of investors as stewards of the commons. While... View Details
Keywords: Collaboration; Industry Self-regulation; Sustainability; ESG; Capital Markets; Investor Behavior; Investment Activism; Social Issues; Environmental Sustainability; Corporate Social Responsibility and Impact; Cooperation
Citation
SSRN
Find at Harvard
Related
Serafeim, George. "Investors as Stewards of the Commons?" Journal of Applied Corporate Finance 30, no. 2 (Spring 2018): 8–17.
  • 08 Jul 2014
  • First Look

First Look: July 8

plans-epitomized by the ubiquitous 401(k)-which transfer the investment risk from the company to the employee. With that transfer has come a dangerous shift in investment focus, argues Nobel Laureate Robert... View Details
Keywords: Carmen Nobel
  • 04 Nov 2015
  • HBS Seminar

Christian Fons-Rosen, Assistant Professor, Universitat Pompeu Fabra, Department of Economics

  • 18 Nov 2008
  • First Look

First Look: November 18, 2008

the position of Brand Development Manager (BDM) to build the company's presence, sales, and relationships with its retail customers. After one year, the CEO, CFO and President must evaluate the impact of the BDM on retail customers, the... View Details
Keywords: Martha Lagace
  • 15 Feb 2000
  • Research & Ideas

The Right Connections

pharmaceutical companies — what the authors call downstream social capital — had a direct impact on the size of the startup's IPO. "Downstream social capital was essential in attracting the interest of a top View Details
Keywords: by Judith A. Ross
  • 15 Apr 2010
  • Working Paper Summaries

The Consequences of Entrepreneurial Finance: A Regression Discontinuity Analysis

Keywords: by William R. Kerr, Josh Lerner & Antoinette Schoar
  • December 2018 (Revised June 2021)
  • Case

Bulb 2015: Foundation

By: John R. Wells and Benjamin Weinstock
In late August 2015, Amit Gudka and Hayden Wood, co-founders of Bulb, Ltd (Bulb), were ready to offer affordable renewable energy to the United Kingdom’s 27 million households. They hoped to capitalize on the hundreds of thousands of customers switching their energy... View Details
Keywords: Green Energy; Start-up; Launch; Customer Acquisition; Customer Churn; Customer Engagement; Electricity; Resources; Growth Strategy; B-Corp; Entrepreneurial Journey; Entrepreneurial Management; Start-ups; Renewable Energy; Business Startups; Business Plan; Business Model; Working Capital; Customers; Growth and Development Strategy; United Kingdom
Citation
Educators
Purchase
Related
Wells, John R., and Benjamin Weinstock. "Bulb 2015: Foundation." Harvard Business School Case 719-440, December 2018. (Revised June 2021.)
  • 04 Feb 2022
  • Blog Post

Learning from the Entrepreneurs-in-Residence as a Harvard MS/MBA Student

planning and operations roles at Blue Apron, Peloton, and Burrow. Ash is also an investment partner at The MBA Fund, an early-stage fund that backs student and alumni founders from Harvard, Stanford, and the... View Details
  • 15 Aug 2019
  • Blog Post

The Social Enterprise Initiative at HBS

impact investing. I thought, 'How can I use impact investing and tie in for profit principles to have an impact?' Impact has been in my blood for... View Details
  • January 2013 (Revised January 2015)
  • Case

FX Risk Hedging at EADS

By: W. Carl Kester, Vincent Dessain and Karol Misztal
In 2008, EADS, the European aerospace group that owns Airbus, was faced with the decision of how best to hedge a large and growing mismatch between its dollar revenues and its euro manufacturing costs. Specifically, the company needed to decide if it would continue... View Details
Keywords: Derivatives; Foreign Exchange; Options; Forward Contract; Aerospace; Europe; Risk Management; Futures and Commodity Futures; Aerospace Industry; Europe
Citation
Educators
Purchase
Related
Kester, W. Carl, Vincent Dessain, and Karol Misztal. "FX Risk Hedging at EADS." Harvard Business School Case 213-080, January 2013. (Revised January 2015.)
  • June 2010 (Revised January 2019)
  • Case

The Guggenheims and Chilean Nitrates

By: Geoffrey Jones and Felipe Tamega Fernandes
The case describes the growth of Guggenheim Brothers as one of the largest mining companies in the world in the early twentieth century. Global expansion led the firm to Chile, first in copper and later in natural nitrates. Chile's economic growth was driven by the... View Details
Keywords: History; Venture Capital; Business History; Entrepreneurship; Globalization; Foreign Direct Investment; Financial Crisis; Mining Industry; Chile
Citation
Educators
Purchase
Related
Jones, Geoffrey, and Felipe Tamega Fernandes. "The Guggenheims and Chilean Nitrates." Harvard Business School Case 810-141, June 2010. (Revised January 2019.)
  • November 2002
  • Case

Siemens ShareNet: Building a Knowledge Network

By: Alan D. MacCormack, Sven Volpel and Kerry Herman
Describes the development of ShareNet, an innovative knowledge management system used by a division of Siemens. ShareNet attempts to capture the knowledge and experience of Siemen's many dispersed sales and marketing units around the globe, making it available to all.... View Details
Keywords: Cost Management; Investment Return; Revenue; Knowledge Acquisition; Knowledge Management; Sales
Citation
Educators
Purchase
Related
MacCormack, Alan D., Sven Volpel, and Kerry Herman. "Siemens ShareNet: Building a Knowledge Network." Harvard Business School Case 603-036, November 2002.
  • 25 Sep 2023
  • Blog Post

HBS Latino Student Association Spotlight: Ana Barrera (MBA 2024)

difference in the world, Harvard provides the platform to develop the critical skills and connections to challenge the status quo. For me, that means championing investment in the educational and financial empowerment of underserved... View Details
  • October 2018 (Revised September 2022)
  • Case

Stock-Based Compensation at Twitter

By: Jonas Heese, Zeya Yang and Mike Young
Olivia Nash, an analyst at leading hedge fund BlueShark Capital Management, had just finished listening to the hour-long earnings call for Twitter’s Q4 2017 results. Was Twitter doing well? That depended on which numbers she chose to believe. According to Generally... View Details
Keywords: Twitter; Non-GAAP Disclosure; Stock-based Compensation; Earnings Management; Corporate Disclosure; Compensation and Benefits; Stocks; Measurement and Metrics
Citation
Educators
Purchase
Related
Heese, Jonas, Zeya Yang, and Mike Young. "Stock-Based Compensation at Twitter." Harvard Business School Case 119-032, October 2018. (Revised September 2022.)
  • Program

Advanced Management Program

impact on organizational direction and performance. Ideal candidates include: Officers or senior executives with responsibility for the success of the organization C-suite-level executives at midsize organizations that have significant... View Details
  • May–June 2023
  • Article

Should Your Start-up Be For-profit or Nonprofit?: A Guide for Social Entrepreneurs

By: Cait Brumme and Brian Trelstad
Years ago the line between nonprofit and for-profit enterprises was clear, but that has changed. Nonprofits now offer products that compete with those of the best for-profits, and for-profits can deliver as much social value as charities. Despite the blurred... View Details
Keywords: Business Startups; Social Entrepreneurship; Mission and Purpose; Nonprofit Organizations; For-Profit Firms; Decision Choices and Conditions
Citation
Register to Read
Related
Brumme, Cait, and Brian Trelstad. "Should Your Start-up Be For-profit or Nonprofit? A Guide for Social Entrepreneurs." Harvard Business Review 101, no. 3 (May–June 2023): 136–145.
  • April 2017
  • Supplement

Imprimis (D)

By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case is a supplement to Imprimis (A, B, & C). It describes Imprimis’s 2015 decision to develop a $1 per pill compounded alternative to Daraprim, the branded drug that had recently undergone an extreme price hike, raising its price to $750 per pill. Imprimis also... View Details
Keywords: Decision Choices and Conditions; Growth and Development Strategy; Pharmaceutical Industry; United States
Citation
Purchase
Related
Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (D)." Harvard Business School Supplement 717-498, April 2017.
  • 08 Sep 2008
  • HBS Case

The Value of Environmental Activists

There are many methods, most financial, to measure the success of companies in meeting goals. But the question becomes a lot harder at Harvard Business School when MBAs are challenged to measure the efforts of environmental organizations like Greenpeace and the World... View Details
Keywords: by Sarah Jane Gilbert; Energy; Utilities
  • ←
  • 81
  • 82
  • …
  • 273
  • 274
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.